(ATII) Archimedes Tech SPAC - Overview
Sector: Financial Services | Industry: Shell Companies | Exchange: NASDAQ (USA) | Market Cap: 331m USD | Total Return: 10.9% in 12m
Avg Turnover: 3.19M
Warnings
Share dilution 360.0% YoY
Tailwinds
Supp Ema8
Archimedes Tech SPAC Partners II Co. (ATII) is a special purpose acquisition company (SPAC) incorporated in 2024 and based in Delaware. The entity maintains no active commercial operations, functioning instead as a blank-check vehicle designed to facilitate a merger, asset acquisition, or reorganization with a target company within the technology sector.
The SPAC business model relies on raising capital through an initial public offering to fund the acquisition of a private entity, effectively providing the target company a streamlined path to public markets. Within the technology sector, such vehicles often target high-growth sub-sectors like software-as-a-service (SaaS) or artificial intelligence to leverage public market liquidity for scaling operations.
Investors can further evaluate the risk profile of this acquisition vehicle by reviewing data on ValueRay. As a newly listed small-cap entity in the financials sector, the company’s primary value remains contingent on the management teams ability to identify and execute a favorable business combination.
- Target business combination announcement in the technology sector
- Trust account redemption rates during shareholder merger approval votes
- Deadline for completing initial business combination under SPAC charter
- Sponsor experience and track record in identifying growth technology targets
| Net Income: error (cannot be calculated; needs Net Income TTM and Revenue TTM) |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA -0.29 > 1.0 |
| NWC/Revenue: error (cannot be calculated; needs Current Assets/Liabilities and Revenue current+prev) |
| CFO/TA -0.00 > 3% & CFO -694k > Net Income 8.53m |
| Net Debt/EBITDA: error (cannot be calculated) |
| Current Ratio: 3.94 > 1.5 & < 3 |
| Outstanding Shares: last quarter (23.0m) vs 12m ago 360.0% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 0.0% > 50% (prev 0.0%; Δ 0.0% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBITDA TTM and Interest Expense TTM) |
| A: 0.00 (Total Current Assets 1.22m - Total Current Liabilities 309k) / Total Assets 243.2m |
| B: -0.03 (Retained Earnings -7.14m / Total Assets 243.2m) |
| C: -0.00 (EBIT TTM -1.06m / Avg Total Assets 238.9m) |
| D: 28.10 (Book Value of Equity 234.9m / Total Liabilities 8.36m) |
| Altman-Z'' = 29.40 = AAA |
As of May 30, 2026, the stock is trading at USD 11.22 with a total of 495,019 shares traded.
Over the past week, the price has changed by +0.18%,
over one month by +5.06%,
over three months by +6.55% and
over the past year by +10.87%.
Archimedes Tech SPAC has no consensus analysts rating.
P/E Trailing = 37.3333
P/B = 1.4123
Revenue TTM = 0.0 USD
EBIT TTM = -1.06m USD
EBITDA TTM = -1.06m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 330.3m USD (331.4m + (null Debt) - CCE 1.08m)
Interest Coverage Ratio = unknown (Ebit TTM -1.06m / Interest Expense TTM 0.0)
EV/FCF = -476.2x (Enterprise Value 330.3m / FCF TTM -694k)
FCF Yield = -0.21% (FCF TTM -694k / Enterprise Value 330.3m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = 1.36 (Enterprise Value 330.3m / Total Assets 243.2m)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = -835k (EBIT -1.06m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 3.94 (Total Current Assets 1.22m / Total Current Liabilities 309k)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA -1.06m)
Debt / FCF = unknown (Net Debt none / FCF TTM -694k)
Total Stockholder Equity = 232.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.57% (Net Income 8.53m / Total Assets 243.2m)
RoE = 3.57% (Net Income TTM 8.53m / Total Stockholder Equity 239.1m)
RoCE = -0.44% (EBIT -1.06m / Capital Employed (Total Assets 243.2m - Current Liab 309k))
RoIC = -0.35% (negative operating profit) (NOPAT -835k / Invested Capital 241.8m)
WACC = 6.23% (E(331.4m)/V(331.4m) * Re(6.23%) + (debt-free company))
Discount Rate = 6.23% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 31.50 | Cagr: -5.52%
[DCF] Fair Price = unknown (Cash Flow -694k)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: N/A | Revenue CAGR: N/A | SUE: N/A | # QB: 0